Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8631 |
High Similarity |
NPD7228 |
Approved |
0.8333 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8323 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.828 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.8218 |
Intermediate Similarity |
NPD7240 |
Approved |
0.8204 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8204 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8204 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8118 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.8103 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8103 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8057 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8046 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8024 |
Intermediate Similarity |
NPD37 |
Approved |
0.7989 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7988 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7976 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7966 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7933 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7919 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.791 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7872 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7853 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7821 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7821 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7821 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7809 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7785 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7785 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7771 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7765 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7758 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7754 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7725 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7709 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.764 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.763 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7542 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7532 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7514 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7486 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7473 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7468 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7371 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7356 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7356 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.734 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7317 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7278 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7247 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7238 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7232 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7216 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7216 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7195 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7195 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7167 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7159 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7159 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7111 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7104 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7101 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7093 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.709 |
Intermediate Similarity |
NPD6842 |
Approved |
0.709 |
Intermediate Similarity |
NPD6841 |
Approved |
0.709 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.7089 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7089 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7089 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7086 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7072 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7062 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7059 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7045 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7037 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.703 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7022 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7021 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7021 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.6977 |
Remote Similarity |
NPD5058 |
Phase 3 |
0.6959 |
Remote Similarity |
NPD3750 |
Approved |
0.6951 |
Remote Similarity |
NPD7095 |
Approved |
0.6944 |
Remote Similarity |
NPD3749 |
Approved |
0.6944 |
Remote Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.6936 |
Remote Similarity |
NPD1511 |
Approved |
0.6932 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6928 |
Remote Similarity |
NPD3620 |
Phase 2 |
0.6928 |
Remote Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD5403 |
Approved |
0.691 |
Remote Similarity |
NPD6801 |
Discontinued |
0.6909 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6909 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6899 |
Remote Similarity |
NPD1357 |
Approved |
0.6897 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6897 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6886 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6886 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6885 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6884 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6882 |
Remote Similarity |
NPD5762 |
Approved |
0.6882 |
Remote Similarity |
NPD5763 |
Approved |
0.6875 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6867 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.686 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.686 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6859 |
Remote Similarity |
NPD8434 |
Phase 2 |
0.6857 |
Remote Similarity |
NPD1512 |
Approved |
0.6857 |
Remote Similarity |
NPD6273 |
Approved |
0.6857 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6845 |
Remote Similarity |
NPD6653 |
Approved |
0.6836 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6833 |
Remote Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.6826 |
Remote Similarity |
NPD4140 |
Approved |
0.6816 |
Remote Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.6807 |
Remote Similarity |
NPD6798 |
Discontinued |
0.68 |
Remote Similarity |
NPD7447 |
Phase 1 |
0.68 |
Remote Similarity |
NPD5401 |
Approved |
0.6798 |
Remote Similarity |
NPD7028 |
Phase 2 |
0.679 |
Remote Similarity |
NPD2983 |
Phase 2 |
0.679 |
Remote Similarity |
NPD2982 |
Phase 2 |
0.679 |
Remote Similarity |
NPD4749 |
Approved |
0.6786 |
Remote Similarity |
NPD5735 |
Approved |
0.678 |
Remote Similarity |
NPD7827 |
Phase 1 |
0.6778 |
Remote Similarity |
NPD2978 |
Approved |
0.6778 |
Remote Similarity |
NPD2977 |
Approved |
0.6766 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6766 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6765 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6765 |
Remote Similarity |
NPD7874 |
Approved |
0.676 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.675 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6747 |
Remote Similarity |
NPD4625 |
Phase 3 |
0.6744 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6743 |
Remote Similarity |
NPD4357 |
Discontinued |
0.6743 |
Remote Similarity |
NPD7212 |
Phase 2 |
0.6743 |
Remote Similarity |
NPD7213 |
Phase 3 |
0.6743 |
Remote Similarity |
NPD6799 |
Approved |
0.6742 |
Remote Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.6742 |
Remote Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.6736 |
Remote Similarity |
NPD7906 |
Approved |
0.6734 |
Remote Similarity |
NPD6778 |
Approved |
0.6734 |
Remote Similarity |
NPD6779 |
Approved |
0.6734 |
Remote Similarity |
NPD6776 |
Approved |
0.6734 |
Remote Similarity |
NPD6780 |
Approved |
0.6734 |
Remote Similarity |
NPD6782 |
Approved |
0.6734 |
Remote Similarity |
NPD6781 |
Approved |
0.6734 |
Remote Similarity |
NPD6777 |
Approved |
0.6731 |
Remote Similarity |
NPD5283 |
Phase 1 |
0.673 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.6728 |
Remote Similarity |
NPD2981 |
Phase 2 |
0.6727 |
Remote Similarity |
NPD3018 |
Phase 2 |
0.6716 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6716 |
Remote Similarity |
NPD7698 |
Approved |
0.6716 |
Remote Similarity |
NPD7697 |
Approved |
0.6705 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6705 |
Remote Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.6705 |
Remote Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.6705 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6704 |
Remote Similarity |
NPD6599 |
Discontinued |
0.6702 |
Remote Similarity |
NPD8156 |
Discontinued |
0.6686 |
Remote Similarity |
NPD1933 |
Approved |
0.6686 |
Remote Similarity |
NPD4340 |
Discontinued |
0.6686 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6686 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6684 |
Remote Similarity |
NPD7039 |
Approved |
0.6684 |
Remote Similarity |
NPD7038 |
Approved |
0.6683 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6683 |
Remote Similarity |
NPD8319 |
Approved |
0.6667 |
Remote Similarity |
NPD3748 |
Approved |
0.6667 |
Remote Similarity |
NPD6971 |
Discontinued |
0.6667 |
Remote Similarity |
NPD7466 |
Approved |
0.6667 |
Remote Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD5588 |
Approved |
0.6667 |
Remote Similarity |
NPD7843 |
Approved |
0.6667 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD7585 |
Approved |
0.665 |
Remote Similarity |
NPD7801 |
Approved |
0.6649 |
Remote Similarity |
NPD8251 |
Approved |
0.6649 |
Remote Similarity |
NPD8099 |
Discontinued |
0.6649 |
Remote Similarity |
NPD8252 |
Approved |
0.6648 |
Remote Similarity |
NPD5353 |
Approved |
0.6646 |
Remote Similarity |
NPD7157 |
Approved |
0.663 |
Remote Similarity |
NPD3382 |
Approved |
0.663 |
Remote Similarity |
NPD919 |
Approved |
0.663 |
Remote Similarity |
NPD3384 |
Approved |
0.663
|
Remote Similarity |
NPD3383 |
Approved |